In a trial of 39 patients with KIT D816V mutated SM, 89% of patients with ASM were found to have at least one additional non-KIT mutation compared with only 25% of patients diagnosed with indolent or smoldering SM. This evidence concerns the gene KIT and systemic mastocytosis.